Cite

HARVARD Citation

    Liang, H. et al. (2019). Inhibition of cyclin E1 overcomes temozolomide resistance in glioblastoma by Mcl‐1 degradation. Molecular carcinogenesis. 58 (8), pp. 1502-1511. [Online]. 
  
Back to record